Raška Karel

Jr., Prof., M.D., Ph.D., F.C.A.P.
Born May 26, 1939 in Prague

  • Honorary member of Learned Society since 2003

Educational and professional preparation

  • 1956, graduate, 14th eleven-year secondary school, Prague;
  • 1956-1962, Third Faculty of Medicine, Charles University (CU);
  • 1962, MUDr.; post-graduate student, Institute of Organic Chemistry and Biochemistry, Czechoslovak Academy of Sciences (CSAS);
  • 1965, CSc.,
  • 1965-1966, postdoctoral fellow, Yale University School of Medicine, New Haven, Connecticut (USA);
  • 1966-1967, research associate, Rutgers University, New Brunswick, New Jersey (USA);
  • 1973-1976, resident in pathology, Rutgers Medical School, Piscataway, New Jersey;
  • professional certificates: Educational Commission for Foreign Medical Graduates (ECFMG), FLEX (flexible spending accounts), American Board of Pathology: anatomic and clinical, immuno-pathology, medical licences: New Jersey, New York, Maine; bioanalytical laboratory director license: New Jersey.

Employment and academic positions

  • 1967-1968, scientist, Institute of Organic Chemistry and Biochemistry, CSAS;
  • 1968-1971, Assistant Professor, Rutgers Medical School;
  • 1969, Professor, Graduate Faculty, Rutgers University;
  • 1971-1976, Associate Professor, Rutgers Medical School;
  • 1976-1986, Professor, Rutgers Medical School;
  • 1986, Professor, Robert Wood Johnson Medical School;
  • 1989-1992, Head, Department of Laboratory Medicine and Pathology, University of Medicine and Dentistry, New Jersey (UMDNJ)-New Jersey Medical School, Newark, New Jersey (USA);
  • 1989-1992, Head, Department of Experimental Pathology, UMDNJ-Graduate School of Biomedical Sciences, Newark;
  • 1992, Head, Department of Laboratory Medicine and Pathology, St. Peter’s University Hospital, New Brunswick;
  • 1992, Head, Institute for Molecular Diagnostics and Pathology, New Brunswick
  • 2004, Professor of Pathology, Drexel University College of Medicine, Philadelphia, Pa (USA)

Membership in domestic scientific bodies (selection)

  • 1994, Foreign (honorary) member, Scientific Council, FMP, CU

Membership and positions in international organizations and societies

  • 1970, American Society for Investigative Pathology
  • 1970, American Society for Microbiology
  • 1976, American Association of Immunologists
  • 1976, American Society for Cell Biology
  • 1976, American Association for Cancer Research
  • 1976, New Jersey Society of Pathologists
  • 1976, International Academy of Pathology
  • 1976, Society for Experimental Biology and Medicine
  • 1982, College of American Pathologists
  • 1982, American Society for Virology
  • 1984, Association of University Pathologists (Pluto club); President 1986, 1989, 1994
  • 1989, Sigma-Xi
  • 1994, Czechoslovak Society of Arts and Sciences, Washington,DC (USA), 2004 Vice-President, 2006-2012 President

Editorial boards

  • 1986-1993, Proceedings of the Society for Experimental Biology and Medicine
  • 1987, Experimental Therapeutics
  • 1985-1992, Member, Special Review Committees, The National Institutes of Health, Bethesda, Maryland (USA) (National Eye Institute, National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases)
  • 1985-1988, New Jersey State Department of Health Advisory Committee on HIV testing
  • 1989-1994, New Jersey State Department of Health Advisory Committee on Laboratory Standardization
  • 1984-1987, 1996, Executive Council, Robert Wood Johnson Medical School
  • 1989-1992, Faculty Council, New Jersey, Medical School
  • 1991-2001, Board of Trustees, New Jersey Organ and Tissue Sharing Network
  • 1992, Executive Committee, St. Peter´s University Hospital
  • 1993, Advisory Board, Cancer Institute of New Jersey

Notable awards

  • 1966, Award, CSAS (for study of 5-azacytidine)
  • 1965, Fellowship, Commonwealth Fund, New York (USA)
  • 1976, 1978, 1982, „Best teacher“, Rutgers Medical School
  • 1993, Honorary Professor of Molecular Biology, Third Faculty of Medicine, CU
  • 1995, 1998, 2002, 2004, elected to „Best Doctors in America“
  • 1995, 1998, 2002, 2004-2012, elected to "Best Doctors in America"
  • 2009, Prize of the Society of Arts and Sciences, Prague
  • 2010, Silver Medal of the senate of the parliament of the Czech republic
  • 2010, Medal of Merit, Ist Grade, in Science, Czech republic

Selected publications

  • K. Raška, Jr., D. Frohwirth, R. W. Schlesinger: Transfer RNA in KB Cells Infected with Adenovirus Type 2. J. Virol. 5, 464, (1970)
  • J. E. Zimmerman, K. Raška, Jr.: Inhibition of adenovirus Type 12 Induced DNA Synthesis in G1 Arrested BHK21 Cells by Dibutyryl Adenosine Cyclic 3': 5'-Monophosphate. Nature New Biology 239, 145 (1972)
  • K. K. Biron, K. Raška, Jr.: Purification of Adenovirus Type 12 Tumor Antigen from Transformed Hamster Cells. Virology 76, 516 (1977)
  • K. Raška, Jr., A. B. Morrison, J. Rašková: Humoral inhibitors of the Immune Response in Uremia. II. Immunosuppressive Factor of Uremic Rat Serum is a Very Low Density Lipoprotein. Laboratory Investigation 42, 636 (1980)
  • K. Raška, Jr., P. H. Gallimore: an Inverse Relation of the oncogenic Potential of Adenovirus Transformed Cells and Their Sensitivity to Killing by Syngeneic Natural Killer Cells. Virology 123, 8 (1982)
  • K. Raška, Jr., J. Rašková et al: T Cell Subsets and Cellular immunity in End Stage Renal Disease. Amer J. Med. 75: 734 (1983)
  • Y. Sawada, D. Urbanelli, J. Rašková, T. E. Shenk, K. Raška, Jr.: Adenovirus Tumor-Specific Transplantion Antigen is a Function of the E1A Early Region. J. Exp. Med. 163, 563 (1986)
  • K. Raška, Jr., et al.: Human Immunodeficiency Virus Infection in Hemophiliacs: Long-Term Prognostic Significance of the HIV Serologic Pattern. Clin. Exp. Immunol. 77, 1 (1989)
  • R. Javier, K. Raška, Jr., T. Shenk: Requirement for the Adenovirus Type 9 E4 Region in Production of Mammary Tumors. Science 257, 1267 (1992)
  • K. Raška, Jr.: Functional Domains of Adenovirus E1A Oncogenes which Control Interactions with Effectors of Cellular Immunity. Current Topics Microbiol. and Immunol. 199/III, 131 (1995)

Zpět na seznam článků

Novinky

13.05.21

Vyjádření Učené společnosti České republiky k společenské situaci v souvislosti s výbuchem ve Vrběticích

Členové Učené společnosti České republiky se na svém XXVII. valném shromáždění 12. května 2021 shodli na prohlášení k aktuální společenské situaci:

Valné shromáždění Učené společnosti České republiky podporuje všechny kroky vedoucí k posílení suverenity České republiky a její příslušnosti k evropským a euroatlantickým strukturám, především Evropské unii a NATO. S nimi je spojena svoboda v naší zemi, základní podmínka pro rozvoj vědy, kultury a vzdělávání, se kterými úzce souvisí i naše současná a zejména budoucí prosperita.

11.05.21

Medaile a ceny Učené společnosti České republiky 2021

Učená společnost České republiky na svém XXVII. valném shromáždění 11. května 2021 udělila medaile za zásluhy o rozvoj vědy a ceny významným vědcům, úspěšným pedagogům a talentovaným středoškolským studentům.

06.05.21

XXVII. valné shromáždění Učené společnosti 11. 5. – 12. 5. 2021

Učená společnost ČR Vás srdečně zve ke sledování slavnostní části XXVII. valného shromáždění, které se koná 11. 5. 2021 od 10:30 hod. Na shromáždění budou předány medaile za zásluhy o rozvoj vědy a ceny Učené společnosti za rok 2020 a 2021. Od 11:30 hod. následuje série přednášek předních odborníků na téma "Pandemie infekčního onemocnění covid-19: výzva pro biomedicínu a společenské vědy". Valné shromáždění je možné sledovat živě na YouTube: http://ucenaspolecnost2021.jdem.cz.
Pozvánka (PDF, 150 kB)